3 reasons why consumer healthcare in India is set to take-off
COVID-19 restrictions, access to affordable technology, and an interest in healthy living, means the consumer healthcare industry in India is set to grow.
Prabu specializes in impact investing and innovative financing for disruptive healthcare innovators and enterprises. He has 9+ years of experience in healthcare, strategy consulting, and private equity and manages the healthcare portfolio at Kois across India and global markets. Recently, he has led investments and structured investment vehicles in point-of-care diagnostics and medical supply chain intermediaries.
His past work includes strategy consulting with McKinsey & Co and as medical officer in cardiology and orthopaedic hospitals. He holds an MBA from IIM Ahmedabad and a Bachelor of Medicine from JIPMER.
COVID-19 restrictions, access to affordable technology, and an interest in healthy living, means the consumer healthcare industry in India is set to grow.
The private sector is facing unprecedented difficulties in accessing finance at a time when it is sorely needed. Could impact finance provide the answer?